Poor
Not Aligned
Patient Risk:
Moderate
Summary
Partial alignment with label-supported liver-function monitoring recommendations, but multiple materially specific claims (monitoring frequency after start, symptom lists, mechanistic biophysiology) are not supported by the provided label text. A direct contradiction is present regarding kidney-damage prevention.
Category Scores
Accurate Statements
Lipitor is also known as atorvastatin.
11 DESCRIPTION
Lipitor is a statin medication that belongs to the class of HMG-CoA reductase inhibitors.
11 DESCRIPTION; 12.1 Mechanism of Action
Lipitor reduces low-density lipoprotein (LDL) cholesterol in the blood.
12.1 Mechanism of Action
Statins like Lipitor can cause liver damage in some individuals.
5.2 Liver Dysfunction
The risk of liver damage with statins like Lipitor is higher in individuals with pre-existing liver disease.
5.2 Liver Dysfunction
The risk of liver damage with statins like Lipitor is higher in individuals who consume excessive amounts of alcohol.
5.2 Liver Dysfunction
Liver damage with statins like Lipitor can manifest as elevated liver enzymes.
5.2 Liver Dysfunction; 17.2 Liver Enzymes
Elevated levels of liver enzymes such as ALT and AST can indicate liver damage or disease.
5.2 Liver Dysfunction; 8.6 Hepatic Impairment
Liver tests are performed at the start of treatment.
5.2 Liver Dysfunction (performed prior to initiation)
Individuals with pre-existing liver disease should exercise caution when taking Lipitor.
5.2 Liver Dysfunction
Excessive alcohol consumption can increase the risk of liver damage during Lipitor use.
5.2 Liver Dysfunction
Unsupported Statements
The liver plays a vital role in metabolizing Lipitor.
Not supported by the provided label excerpts.
Liver damage or dysfunction can lead to increased levels of Lipitor in the blood.
Not supported by the provided label excerpts.
Liver enzymes such as alanine transaminase (ALT) and aspartate transaminase (AST) are proteins produced by the liver.
Not supported by the provided label excerpts.
Liver tests are essential during Lipitor use to monitor liver health and detect potential liver damage.
Label excerpts recommend liver function tests, but do not state they are 'essential' for 'liver health' or 'detect potential liver damage' in those terms.
Liver tests during Lipitor use can help identify individuals who may be at risk of liver damage during Lipitor use.
Not supported by the provided label excerpts.
Liver tests during Lipitor use are typically performed every 3-6 months during the first year.
Not supported by the provided label excerpts.
Liver tests during Lipitor use are typically performed annually thereafter.
Not supported by the provided label excerpts.
Signs of liver damage during Lipitor use may include fatigue.
Not supported by the provided label excerpts.
Signs of liver damage during Lipitor use may include loss of appetite.
Not supported by the provided label excerpts.
Signs of liver damage during Lipitor use may include nausea and vomiting.
Not supported by the provided label excerpts.
Signs of liver damage during Lipitor use may include abdominal pain.
Not supported by the provided label excerpts.
Signs of liver damage during Lipitor use may include dark urine.
Not supported by the provided label excerpts.
Signs of liver damage during Lipitor use may include pale stools.
Not supported by the provided label excerpts.
For individuals with pre-existing liver disease, a healthcare provider may recommend alternative treatments or adjust Lipitor dosage to minimize risk of liver damage.
Not supported by the provided label excerpts.
Individuals who consume more than 4 drinks per day should avoid taking Lipitor or consult their healthcare provider for guidance.
Not supported by the provided label excerpts.
Individuals with kidney disease should exercise caution when taking Lipitor.
Not supported by the provided label excerpts.
For individuals with kidney disease, a healthcare provider may recommend alternative treatments or adjust Lipitor dosage to minimize the risk of kidney damage.
Not supported by the provided label excerpts.
Monitoring liver health during Lipitor use can help prevent other complications.
Not supported by the provided label excerpts.
Contradictions
Low
AI Statement
Monitoring liver health during Lipitor use can help prevent kidney damage.
Label Reference
5.2 Liver Dysfunction (no statement regarding kidney-damage prevention)
Important Omissions
No evaluation possible for boxed warnings, contraindications details, drug interactions, or comprehensive adverse reaction profile because none of those label elements were addressed in the provided claim set.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Unsupported and overly specific monitoring-frequency and symptom-related claims could mislead expectations about when to test and what clinical signs to look for; a contradiction exists regarding kidney-damage prevention. However, several core liver-function monitoring recommendations and risk factors (alcohol/substantial alcohol, history of liver disease, and use of LFTs at initiation and dose changes) are aligned.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Aligned
Primary Issue
Multiple claims are not supported by the provided label excerpts, including specific LFT scheduling (3–6 months and annual thereafter) and symptom lists; additionally, there is a direct contradiction regarding preventing kidney damage.
Suggested Improvement
Restrict monitoring statements to what the label excerpt supports (LFTs prior to initiation, at 12 weeks after initiation and after dose increases, and periodically such as semiannually thereafter), remove unsupported symptom lists and unsupported mechanistic/biological claims, and avoid claiming benefits not stated in the label excerpt (e.g., kidney-damage prevention).